1004111-31-2Relevant articles and documents
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy
Bulic, Bruno,Pickhardt, Marcus,Khlistunova, Inna,Biernat, Jacek,Mandelkow, Eva-Maria,Mandelkow, Eckhard,Waldmann, Herbert
, p. 9215 - 9219 (2008/12/22)
Breaking up the crowd: The pathological aggregation of tau protein correlates closely with the progression of Alzheimer's disease. Rhodanine-based inhibitors of tau aggregation (e.g. 1) have been identified, and it has been shown that tau aggregation in a